Viewing Study NCT03771794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-03-13 @ 1:03 PM
Study NCT ID: NCT03771794
Status: UNKNOWN
Last Update Posted: 2018-12-11
First Post: 2018-12-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Heart Rate Variability Augmentation With RR2 Neuromodulation Device
Sponsor: Hillel Yaffe Medical Center
Organization:

Study Overview

Official Title: Non-Invasive Peripheral Neuromodulation to Augment HRV in Healthy Adults
Status: UNKNOWN
Status Verified Date: 2018-12
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Brief Summary: A randomized double-blinded, sham-controlled, crossover study

Condition or Disease: impaired autonomic balance measured by heart rate variability
Detailed Description: A randomized double-blinded, sham-controlled, crossover study

Condition or Disease: impaired autonomic balance measured by heart rate variability

Intervention/treatment:

Device: ReguRate RR2 neurostimulation system Device: Sham ReguRate RR2 neurostimulation system

Study Design:

Study Type: Interventional (clinical trial) Planned enrollment: 60 participants Allocation: Randomized Intervention Model; Cross Over Masking: Double (participant, Investigator) Primary Purpose: Treatment Official Title: Non-Invasive peripheral neuromodulation to augment HRV in healthy adults

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: